About Amgen
Science
Corporate Giving
Site Map
Search
Privacy & Terms
Contact Us
Patients
Medical Professionals
Partners
Investors
Careers
Media
print
mail
Home
Reimbursement Connection®
NCD Overview
Overview
Amgen™ Oncology Assistance
Aranesp®
(darbepoetin alfa)
Neulasta®
(pegfilgrastim)
NEUPOGEN®
(Filgrastim)
EPOGEN®
(Epoetin alfa)
Sensipar®
(cinacalcet)
Enbrel®
(etanercept)
Kepivance®
(palifermin)
Kineret®
(anakinra)
Vectibix®
(panitumumab)
National Coverage Determination
Please find the latest updates below:
Revised ESA NCD Article Posted to MLN Matters
Change Request 5818
CMS ESA draft NCD
CMS press release
NCD: Full document from CMS
Amgen press release
footer